This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

6 Health Care Stocks to Gain on Earnings

1. Omnicell (OMCL - Get Report) provides automated solutions for hospital medication and supply management. It designs solutions to enable healthcare facilities to acquire, manage, dispense and administer medication and medical-surgical supplies. Besides, it is focused on improving patient safety, reducing medication errors, improving workflow, and operating efficiency. The company will release its second quarter 2011 results on July 22.

Analysts polled by Bloomberg expect Omnicell to record second-quarter net income of $4.51 million or 13 cents per share, versus $4.06 million or 12 cents per share in the same quarter prior year. Sales are seen soaring by 9% to $59.87 million from $54.69 million earlier. Gross margin is likely to expand to 54.77% from 52.78%, while EBITDA is estimated to rise to $7.64 million from $5.67 million in the year-ago period. Operating profit is seen rising by 5% during the quarter.

Recently, it was known that president and CEO of the company sold 6,936 shares on July 13 at an average price of $17 per share.

Of the nine analysts covering the stock, 78% recommend a buy and 11% suggest a hold. Analysts polled by Bloomberg foresee the stock gaining an average 5.5% to $17.50 in the upcoming 12 months.

>>To see these stocks in action, visit the 6 Health Care Stocks to Gain on Earnings portfolio on Stockpickr.

6 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CPHD $56.76 -0.91%
EW $134.58 -0.93%
IDXX $157.23 -1.40%
MOH $61.68 -2.77%
MMSI $19.47 -1.37%


DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs